Team The Role of Human Interleukin 8 (IL-8) and ELISA Kits in Asthma: A Technical Analysis Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and bronchial hyperresponsiveness. Human Interleukin 8 (IL-8), a potent chemotactic cytokine, pla... Jun 14, 2024 AffiELISA®
Team Advanced Applications of Human CD4 ELISA Kits in Asthma Pathophysiology and Immunological Research Asthma is a chronic inflammatory disease of the airways, characterized by variable airflow obstruction and bronchial hyperresponsiveness. The immune system, particularly CD4+ T cells, plays a crucial ... Jun 14, 2024 AffiELISA®
Team Development and Validation of a Cysteine Protease Inhibitor C (CST3) ELISA Kit for Neurological Applications Cysteine protease inhibitor C (CST3) plays a crucial role in various neurological processes, including neurodegeneration and neuroinflammation. Accurate quantification of CST3 levels in biological sam... Jun 13, 2024 AffiELISA®
Team Evaluation of VIM ELISA Kit in Brain Cancer Research Vimentin, a key intermediate filament protein, has emerged as a significant biomarker in the context of brain cancer due to its involvement in tumor progression and metastasis. Enzyme-Linked Immunosor... Jun 10, 2024 AffiELISA®
Team Evaluation of VEGFB Expression in Brain Cancer Using ELISA Kit Vascular endothelial growth factor B (VEGFB) is a member of the VEGF family that plays a crucial role in angiogenesis and vascular permeability. Dysregulation of VEGFB expression has been implicated i... Jun 10, 2024 AffiELISA®
Team Quantification of Vascular Endothelial Growth Factor A (VEGFA) Levels in Brain Cancer Using ELISA Assay: A Technical Approach Vascular endothelial growth factor A (VEGFA) is a key regulator of angiogenesis, contributing significantly to the pathogenesis and progression of brain cancer. Quantification of VEGFA levels in brain... Jun 10, 2024 AffiELISA®
Team Detailed Analysis of TNFSF9 ELISA Kit Utilization in Brain Cancer Research TNFSF9, also known as CD137 ligand (CD137L) or 4-1BB ligand (4-1BBL) , is a crucial member of the tumor necrosis factor (TNF) superfamily. It plays a significant role in the immune system, particularl... Jun 10, 2024 AffiELISA®
Team Detection of TNFRSF1A Expression in Brain Cancer Using ELISA Kit: A Technical Approach Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A) plays a pivotal role in mediating various cellular processes, including inflammation and apoptosis. Dysregulation of TNFRSF1A has been i... Jun 10, 2024 AffiELISA®
Team Development and Application of a PDCD1 Elisa Kit for Brain Cancer Research Programmed cell death protein 1 (PDCD1), also known as PD-1, has emerged as a critical regulator of immune responses in various cancers, including brain cancer. In this study, we describe the developm... Jun 10, 2024 AffiELISA®
Team Assessing IL2RA Expression in Brain Cancer: A Technical Guide to ELISA Analysis Interleukin-2 receptor subunit alpha (IL2RA) has emerged as a potential biomarker in brain cancer, with implications for prognosis and treatment response. Enzyme-linked immunosorbent assay (ELISA) rep... Jun 10, 2024 AffiELISA®
Team A Comprehensive Technical Manual for ERBB3 ELISA Assay in Brain Cancer Research The ERBB3 receptor, a member of the epidermal growth factor receptor (EGFR) family, has been implicated in various cancers, including brain cancer. Quantification of ERBB3 expression is crucial for un... Jun 10, 2024 AffiELISA®
Team Precision Quantification of CD47 in Brain Cancer: Insights from ELISA Analysis In the realm of brain cancer research, the investigation of CD47 expression levels has emerged as a pivotal area of interest due to its implications in tumor evasion from the immune system. Enzyme-lin... Jun 10, 2024 AffiELISA®